Phase 2 Lymphoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have given their written agreement to take part in the trial
- People who are 18 years of age or older
- People whose overall health and ability to carry out daily activities meets a certain minimum level, as measured by a standard medical scoring tool (confirm with trial site)
- People who are expected to live for at least 12 weeks
- People who have been diagnosed with a type of blood cancer called peripheral T-cell lymphoma (PTCL), confirmed by laboratory testing of tissue
- People who have measurable signs of the disease that can be tracked during the trial
- People whose bone marrow, organs (such as liver and kidneys), and overall body function meet the required health levels
- People who are able to follow the trial's schedule and complete all required visits and procedures
- People who are willing and able to use adequate contraception throughout their time in the trial
Who may not be able to join:
- People who still have unresolved side effects from a previous treatment that are above a mild level
- People whose lymphoma has spread to the brain or spinal cord
- People who have not waited long enough after finishing other cancer treatments before joining this trial (confirm with trial site)
- People whose use of steroid medicines does not meet the trial's specific requirements (confirm with trial site)
- People who have had major surgery or a significant physical injury recently, or who have major surgery planned in the near future (confirm with trial site for specific timeframes)
- People who have received a live vaccine recently (confirm with trial site for specific timeframe)
- People who are unable to stop taking certain medications that are not permitted during the trial
- People who need to take immune-suppressing medicines or certain biological medicines because of another health condition
- People who have an active infection at the time of joining
- People with serious heart or cardiovascular disease
- People with a stomach or bowel condition that could affect how the study medicine is taken in or absorbed by the body
- People who have a history of another type of cancer
- People who are known to be allergic to the study medicine
- People with other severe or poorly controlled illnesses
- People who work at the trial site or are employed by the company sponsoring the trial, due to a conflict of interest
- People who are pregnant or currently breastfeeding
- People who are unable to follow the trial's procedures and requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86-21-61097800
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Part A: Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]).; Part B: Complete Response Rate (CRR) According to Lugano 2014 by Investigators' Review
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.